Epigenetic Platinum Complexes Breaking the “Eat Me/Don’t Eat Me” Balance for Enhanced Cancer Chemoimmunotherapy-Reference-Cited by-同舟云学术

Epigenetic Platinum Complexes Breaking the “Eat Me/Don’t Eat Me” Balance for Enhanced Cancer Chemoimmunotherapy

Published:2022-01-18 Issue:2 Volume:33 Page:343-352
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Tian Longlong¹²³^ORCID,Shao Ming¹,Gong Yimou¹,Wei Ting¹,Zhu Yujie¹,Chao Yu¹,Liu Zhuang¹^ORCID

Affiliation:

1. Institute of Functional Nano and Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow University, Suzhou, Jiangsu 215123, China

2. Frontiers Science Center for Rare Isotopes, Lanzhou University, Lanzhou 730000, China

3. Institute of Molecular Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China

Funder

National Natural Science Foundation of China

Priority Academic Program Development of Jiangsu Higher Education Institutions

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.bioconjchem.1c00576

Reference47 articles.

1. The rediscovery of platinum-based cancer therapy

2. The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs

3. Stimuli-Responsive Therapeutic Metallodrugs

4. Platinum-Doped Prussian Blue Nanozymes for Multiwavelength Bioimaging Guided Photothermal Therapy of Tumor and Anti-Inflammation

5. BODI-Pt, a Green-Light-Activatable and Carboplatin-Based Platinum(IV) Anticancer Prodrug with Enhanced Activation and Cytotoxicity

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulating macrophage-mediated programmed cell removal: An attractive strategy for cancer therapy;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. Platinum(IV) and platinum(II) anticancer complexes with biologically active releasable ligands;Coordination Chemistry Reviews;2024-02

3. Development of Platinum Complexes for Tumor Chemoimmunotherapy;Chemistry – A European Journal;2024-01-03

4. Polarization of macrophages to an anti-cancer phenotype through in situ uncaging of a TLR 7/8 agonist using bioorthogonal nanozymes;Chemical Science;2024

5. Metabolic reprogramming of three major nutrients in platinum-resistant ovarian cancer;Frontiers in Oncology;2023-08-22